title: Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement.
abstract: METHODS
  Update of the US Preventive Services Task Force (USPSTF) recommendation on screening for impaired visual acuity in older adults.
  
  
  METHODS
  The USPSTF reviewed the evidence on screening for visual acuity impairment associated with uncorrected refractive error, cataracts, and age-related macular degeneration among adults 65 years or older in the primary care setting; the benefits and harms of screening; the accuracy of screening; and the benefits and harms of treatment of early vision impairment due to uncorrected refractive error, cataracts, and age-related macular degeneration.
  
  
  METHODS
  This recommendation applies to asymptomatic adults 65 years or older who do not present to their primary care clinician with vision problems.
  
  
  CONCLUSIONS
  The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for impaired visual acuity in older adults. (I statement).
authors.affiliation: Mount Sinai School of Medicine, New York2James J. Peters Veterans Affairs Medical Center, Bronx, New York.
authors.forename: Albert L
authors.initials: AL
authors.lastname: Siu
authors.affiliation: University of California, San Francisco.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Bibbins-Domingo
authors.affiliation: Group Health Research Institute, Seattle, Washington.
authors.forename: David C
authors.initials: DC
authors.lastname: Grossman
authors.affiliation: University of Wisconsin, Madison.
authors.forename: Linda Ciofu
authors.initials: LC
authors.lastname: Baumann
authors.affiliation: Columbia University, New York, New York.
authors.forename: Karina W
authors.initials: KW
authors.lastname: Davidson
authors.affiliation: University of Georgia, Athens.
authors.forename: Mark
authors.initials: M
authors.lastname: Ebell
authors.affiliation: Pima County Department of Health, Tucson, Arizona.
authors.forename: Francisco A R
authors.initials: FA
authors.lastname: García
authors.affiliation: Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
authors.forename: Matthew
authors.initials: M
authors.lastname: Gillman
authors.affiliation: Independent consultant, Washington, DC.
authors.forename: Jessica
authors.initials: J
authors.lastname: Herzstein
authors.affiliation: Duke University, Durham, North Carolina.
authors.forename: Alex R
authors.initials: AR
authors.lastname: Kemper
authors.affiliation: Fairfax Family Practice, Fairfax, Virginia13Virginia Commonwealth University, Richmond.
authors.forename: Alex H
authors.initials: AH
authors.lastname: Krist
authors.affiliation: New York University, New York.
authors.forename: Ann E
authors.initials: AE
authors.lastname: Kurth
authors.affiliation: Veterans Affairs Palo Alto Health Care System, Palo Alto, California16Stanford University, Stanford, California.
authors.forename: Douglas K
authors.initials: DK
authors.lastname: Owens
authors.affiliation: University of Washington, Seattle.
authors.forename: William R
authors.initials: WR
authors.lastname: Phillips
authors.affiliation: Brown University, Providence, Rhode Island.
authors.forename: Maureen G
authors.initials: MG
authors.lastname: Phipps
authors.affiliation: University of North Carolina, Chapel Hill.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Pignone
mesh_terms: D026683:Advisory Committees; D000368:Aged; D002386:Cataract / Q000150:complications; D042241:Early Diagnosis; D006801:Humans; D008268:Macular Degeneration / Q000150:complications; D012030:Refractive Errors / Q000150:complications; D018570:Risk Assessment; D014786:Vision Disorders / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D015351:Vision Screening; D014792:Visual Acuity